Brands: Depo-Medrol · Methylprednisolone Acetate
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Pharmacia & Upjohn Company LLC | unknown | 11 | SUPPLYING |
| Sandoz Inc | generic | 3 | SUPPLYING |
| A-S Medication Solutions | repackager | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.
cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.
Methylprednisolone Acetate Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Rheumatology.
Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0 — Recalling firm: Pfizer Inc. — Nationwide
